Hydroxychloroquine 200 mg, often referred to as HCQ, is a medication that has gained significant attention in recent times. Originally developed to treat and prevent malaria, it has found applications in managing autoimmune diseases like rheumatoid arthritis and lupus. Its immunomodulatory properties make it valuable in reducing inflammation and alleviating the symptoms associated with these conditions. HCQ's potential use in treating certain viral infections, including the novel coronavirus, sparked global interest and research. While its efficacy against COVID-19 remains a subject of ongoing study and debate, Hydroxychloroquine 200 mg continues to be an essential component of treatment regimens for those with autoimmune disorders, providing hope for improved quality of life for many.